Biointegrated Implantable Systems for Cell-based Sensing and Therapy
Biointegrated Implantable Systems for Cell-based Sensing and Therapy is an ARPA-H-funded effort led by Carnegie Mellon University researchers who are working to develop a bioelectronic implant to improve care options for patients battling thyroid disorders like hypo- and hyperthyroidism.
Source: Brandon Martin/Rice University
Rx On-site Generation Using Electronics
Rx On-site Generation Using Electronics is an ARPA-H-funded effort led by Carnegie Mellon University researchers who are collaborating to fast-track a bioelectronic implant that could radically improve treatment options and significantly reduce the cost of care for patients with obesity and Type 2 diabetes.
Moonshot
Body, Brain, Behavior: Advancing Neurotechnology for Peak Performance, Health, and Wellbeing
The moonshot will bring together CMU and clinical institutions to ask how physical health, internal and external stressors, and the environment influence the performance of the brain and behavior. It will develop engineering solutions for understanding and optimizing human cognitive performance in the healthy brain, focusing on innovative, translational solutions for treating neural health conditions.
Targeted Hybrid Oncotherapeutic Regulation
As part of the ARPA-H-funded Targeted Hybrid Oncotherapeutic Regulation project, a multi-institutional team of researchers, including Carnegie Mellon University, is working to develop and test a new approach to cancer treatment that aims to dramatically improve immunotherapy outcomes for patients with ovarian, pancreatic, and other difficult-to-treat cancers.